Abstract
The current status and time trends in breast cancer incidence and survival in the 28 European Union countries (EU-28) is presented here. Rates reported are age adjusted and standardized (ASR). A high incidence and high survival rates were observed in the Northern and Western European countries, with the exception of the Baltic countries. The higher incidence is partly attributed to the higher prevalence of lifestyle risk factors, while the higher survival is attributed to better access to beneficial treatments and general health care. Most of the countries in Southern Europe or the former Eastern Bloc have not yet reached the high GDP per capita status (2017 purchasing power parity; PPP) of the earlier established Western democracies. The breast cancer incidence and survival are associated with the PPP level (both higher for the higher PPP category; 2017 PPP above USD 40,000). Overall, a trend toward higher survival rates was observed throughout this first period of the 21st century, with the incidence for most countries either stabilizing at the 2010 levels or decreasing further.
References
1.
2.
Cardoso
F
, Kyriakides
S
, Ohno
S
, Penault-Llorca
F
, Poortmans
P
, Rubio
IT
, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
. Ann Oncol
. 2019
;30
(8
):1194
–220
. 0923-75343.
Iwamoto
Y
, Kaucher
S
, Lorenz
E
, Bärnighausen
T
, Winkler
V
. Development of breast cancer mortality considering the implementation of mammography screening programs - a comparison of western European countries
. BMC Public Health
. 2019
Jun
;19
(1
):823
.
[PubMed]
1471-24585.
Hermon
C
, Beral
V
. Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries
. Br J Cancer
. 1996
Apr
;73
(7
):955
–60
.
[PubMed]
0007-09206.
Ferlay
J
, Colombet
M
, Soerjomataram
I
, Dyba
T
, Randi
G
, Bettio
M
, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018
. Eur J Cancer
. 2018
Nov
;103
:356
–87
.
[PubMed]
0959-80497.
Carioli
G
, Malvezzi
M
, Rodriguez
T
, Bertuccio
P
, Negri
E
, La Vecchia
C
. Trends and predictions to 2020 in breast cancer mortality in Europe
. Breast
. 2017
Dec
;36
:89
–95
.
[PubMed]
0960-97768.
UN
. Country classifications. World Economic Situation and Prospects
. WESP
; 2019
.9.
Kumar
S
, Preetha
G
. Health promotion: an effective tool for global health
. Indian J Community Med
. 2012
Jan
;37
(1
):5
–12
.
[PubMed]
0970-021810.
Gadzicki
D
, Evans
DG
, Harris
H
, Julian-Reynier
C
, Nippert
I
, Schmidtke
J
, et al. Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany
. J Community Genet
. 2011
Jun
;2
(2
):53
–69
.
[PubMed]
1868-310X11.
Janavičius
R
. Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
. EPMA J
. 2010
Sep
;1
(3
):397
–412
.
[PubMed]
1878-507712.
Levy-Lahad
E
, Lahad
A
, King
MC
. Precision medicine meets public health: population screening for BRCA1 and BRCA2
. J Natl Cancer Inst
. 2014
Dec
;107
(1
):420
.
[PubMed]
0027-887413.
Delivorias
A SG
. EU demographic indicators Situation, trends and potential challenges. . European Parliamentary Research Service, Members Research Service.14.
England
K
, Azzopardi-Muscat
N
. Demographic trends and public health in Europe.
European journal of public health. 2017
;27(suppl_4):9-13. 15.
Fitzmaurice
C
, Akinyemiju
TF
, Al Lami
FH
, Alam
T
, Alizadeh-Navaei
R
, Allen
C
, et al.; Global Burden of Disease Cancer Collaboration
. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study
. JAMA Oncol
. 2018
Nov
;4
(11
):1553
–68
.
[PubMed]
2374-243716.
Allemani
C
, Matsuda
T
, Di Carlo
V
, Harewood
R
, Matz
M
, Nikšić
M
, et al.; CONCORD Working Group
. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
. Lancet
. 2018
Mar
;391
(10125
):1023
–75
.
[PubMed]
0140-673617.
Cherny
N
, Sullivan
R
, Torode
J
, Saar
M
, Eniu
A
. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe
. Ann Oncol
. 2016
Aug
;27
(8
):1423
–43
.
[PubMed]
0923-753418.
https://www.worldometers.info/gdp/gdp-per-capita/ assessed on 3 September
2019
.19.
Torre
LA
, Islami
F
, Siegel
RL
, Ward
EM
, Jemal
A
. Global Cancer in Women: burden and Trends
. Cancer Epidemiol Biomarkers Prev
. 2017
Apr
;26
(4
):444
–57
.
[PubMed]
1055-996520.
Boffetta
P
, Boccia
S
, La Vecchia
C.
A quick guide to cancer epidemiology. ix, 101 pages p.21.
Cooter
M
, Soliman
AS
, Pavlou
P
, Demetriou
A
, Orphanides
C
, Kritioti
E
, et al. Incidence and time trends of cancer in Cyprus over 11 years (1998-2008)
. Tumori
. 2015
Jan-Feb
;101
(1
):8
–15
.
[PubMed]
0300-891622.
Kruijshaar
ME
, Barendregt
JJ
; European Disability Weights Group
. The breast cancer related burden of morbidity and mortality in six European countries: the European Disability Weights project
. Eur J Public Health
. 2004
Jun
;14
(2
):141
–6
.
[PubMed]
1101-126223.
Arnold
M
, Karim-Kos
HE
, Coebergh
JW
, Byrnes
G
, Antilla
A
, Ferlay
J
, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
. Eur J Cancer
. 2015
Jun
;51
(9
):1164
–87
.
[PubMed]
0959-804924.
Thun
MJ
, Linet
MS
, Cerhan
JR
, Haiman
C
, Schottenfeld
D
. Schottenfeld and Fraumeni cancer epidemiology and prevention.
Fourth edition. ed. New York, NY: Oxford University Press; 2018
. xix, 1308 pages p.25.
Ellis
L
, Woods
LM
, Estève
J
, Eloranta
S
, Coleman
MP
, Rachet
B
. Cancer incidence, survival and mortality: explaining the concepts
. Int J Cancer
. 2014
Oct
;135
(8
):1774
–82
.
[PubMed]
0020-713626.
Sant
M
, Allemani
C
, Capocaccia
R
, Hakulinen
T
, Aareleid
T
, Coebergh
JW
, et al.; EUROCARE Working Group
. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
. Int J Cancer
. 2003
Sep
;106
(3
):416
–22
.
[PubMed]
0020-713627.
De Angelis
R
, Sant
M
, Coleman
MP
, Francisci
S
, Baili
P
, Pierannunzio
D
, et al.; EUROCARE-5 Working Group
. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE—5-a population-based study
. Lancet Oncol
. 2014
Jan
;15
(1
):23
–34
.
[PubMed]
1470-204528.
Hortobagyi
GN
, de la Garza Salazar
J
, Pritchard
K
, Amadori
D
, Haidinger
R
, Hudis
CA
, et al.; ABREAST Investigators
. The global breast cancer burden: variations in epidemiology and survival
. Clin Breast Cancer
. 2005
Dec
;6
(5
):391
–401
.
[PubMed]
1526-8209© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
